Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas.

Busam KJ, Murali R, Pulitzer M, McCarthy SW, Thompson JF, Shaw HM, Brady MS, Coit DG, Dusza S, Wilmott J, Kayton M, Laquaglia M, Scolyer RA.

Am J Surg Pathol. 2009 Sep;33(9):1386-95. doi: 10.1097/PAS.0b013e3181ac1927.

PMID:
19609204
2.

Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).

Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, Scolyer RA.

Ann Surg Oncol. 2008 Jan;15(1):302-9. Epub 2007 Nov 14.

PMID:
18000712
3.

Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.

Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L.

Cancer. 2003 Jan 15;97(2):499-507.

4.

Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors.

Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ.

Am J Surg Pathol. 2002 Jan;26(1):47-55.

PMID:
11756768
5.

Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features.

Gamblin TC, Edington H, Kirkwood JM, Rao UN.

Ann Surg Oncol. 2006 Dec;13(12):1664-70.

PMID:
17024556
6.

Survival in sentinel lymph node-positive pediatric melanoma.

Roaten JB, Partrick DA, Bensard D, Pearlman N, Gonzalez R, Fitzpatrick J, McCarter MD.

J Pediatr Surg. 2005 Jun;40(6):988-92; discussion 992.

PMID:
15991183
7.

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.

Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS.

Am J Surg Pathol. 2005 Mar;29(3):305-17.

PMID:
15725798
8.

Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms.

Ghazi B, Carlson GW, Murray DR, Gow KW, Page A, Durham M, Kooby DA, Parker D, Rapkin L, Lawson DH, Delman KA.

Ann Surg Oncol. 2010 Sep;17(9):2471-5. doi: 10.1245/s10434-010-1022-3. Epub 2010 Mar 12.

PMID:
20224858
9.

Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008.

Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM.

Pediatr Dermatol. 2010 May-Jun;27(3):244-54. doi: 10.1111/j.1525-1470.2009.01078.x. Epub 2010 Apr 9.

PMID:
20403119
11.

Long-term outcome of Spitz-type melanocytic tumors.

Sepehr A, Chao E, Trefrey B, Blackford A, Duncan LM, Flotte TJ, Sober A, Mihm MC Jr, Tsao H.

Arch Dermatol. 2011 Oct;147(10):1173-9. doi: 10.1001/archdermatol.2011.170. Epub 2011 Jun 16.

12.

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Melanoma Res. 2003 Feb;13(1):35-43.

PMID:
12569283
13.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
14.

Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.

Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.

J Am Acad Dermatol. 2001 May;44(5):762-6.

PMID:
11312421
15.

Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.

Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.

Arch Dermatol. 2005 Aug;141(8):1016-22.

PMID:
16103331
16.

The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.

Ludgate MW, Fullen DR, Lee J, Lowe L, Bradford C, Geiger J, Schwartz J, Johnson TM.

Cancer. 2009 Feb 1;115(3):631-41. doi: 10.1002/cncr.24047.

17.

Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.

Gannon CJ, Rousseau DL Jr, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE.

Cancer. 2006 Dec 1;107(11):2647-52.

18.

Influence of sentinel lymph node tumor burden on survival in melanoma.

Francischetto T, Spector N, Neto Rezende JF, de Azevedo Antunes M, de Oliveira Romano S, Small IA, Gil Ferreira C.

Ann Surg Oncol. 2010 Apr;17(4):1152-8. doi: 10.1245/s10434-009-0884-8. Epub 2010 Jan 20.

PMID:
20087785
19.

Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.

Fincher TR, McCarty TM, Fisher TL, Preskitt JT, Lieberman ZH, Stephens JF, O'Brien JC, Kuhn JA.

Am J Surg. 2003 Dec;186(6):675-81.

PMID:
14672778
20.

Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes.

Joseph E, Brobeil A, Glass F, Glass J, Messina J, DeConti R, Cruse CW, Rapaport DP, Berman C, Fenske N, Reintgen DS.

Ann Surg Oncol. 1998 Mar;5(2):119-25.

PMID:
9527264
Items per page

Supplemental Content

Write to the Help Desk